About this


Meningiomas are the most common tumors occurring in the brain and spine. About 80% of them show benign features responsive to surgery alone. 20%, however, require extensive treatment including repeat surgery, radiation, and/or chemotherapy, and in many cases the tumors still recur. Pediatric meningiomas, however, are extremely rare tumors and are often of the more aggressive form. It is thought that the underlying biology of pediatric meningiomas is different from their adult counterparts, and this study seeks to investigate those differences. Whole Genome Sequencing (WGS), which identifies the base chemicals that make up DNA, will be carried out on specimens from the Pediatric Brain Tumor Atlas. Researchers aim to gain a deeper understanding of pediatric meningiomas that could establish new therapies designed specifically for the pediatric population.

Ask The


Ask the scientists

What are the goals of this project?

Pediatric meningiomas are not as well understood at adult meningiomas and researchers in this project seek to close that knowledge gap in the pursuit of targeted therapies.

What is the impact of this project?

Through addressing the differences between adult and pediatric meningiomas, researchers are paving the way for the development of new targeted therapies for pediatric populations. The data generated will help characterize this tumor type and be shared with the research community.

Why is the CBTN request important to this project?

Pediatric meningiomas are rare tumors, but the Pediatric Brain Tumor Atlas will give researchers access to the specimens needed to carry out this research.

Specimen Data

The Children's Brain Tumor Network contributed to this project by providing access to the Pediatric Brain Tumor Atlas

Explore the data in these informatics portals